Related Experiment Videos
Rheumatic heart diseases in pregnancy
1Department of Cardiology, National Heart Centre of Singapore, 17 Third Hospital Avenue, Singapore 168752.
Annals of the Academy of Medicine, Singapore
|June 14, 2002
Summary
Pregnancy with rheumatic valvular disease, especially mitral stenosis, poses high risks. Careful management and individualized treatment are crucial for maternal and fetal well-being.
Area of Science:
- Cardiology
- Obstetrics
- Rheumatology
Background:
- Rheumatic valvular disease is a leading cause of heart disease in pregnancy.
- Mitral stenosis is the most common rheumatic valvular lesion, often worsened by pregnancy's cardiovascular changes.
Purpose of the Study:
- To review the impact of pregnancy on rheumatic valvular disease.
- To discuss management strategies and recent therapeutic advances for pregnant patients with valvular lesions.
Main Methods:
- Literature review of rheumatic valvular disease in pregnancy.
- Analysis of current and emerging treatment options.
Main Results:
- Severe uncorrected valvular lesions or mechanical valves requiring anticoagulation necessitate pregnancy termination due to high risks.
- Milder disease may be managed with pregnancy after lesion correction or stabilization.
Conclusions:
- Management decisions for pregnant patients with valvular disease must be individualized.
- Balancing risks and benefits is essential for maternal survival and fetal well-being.
- The application of new therapies like beta-blockers, vasodilators, and percutaneous balloon valvuloplasty in pregnancy requires further investigation.